Anti-fungal drug starves tumors
An inexpensive antifungal drug slows tumor growth and shows promise as a chemotherapy for cancer, according to a new study from the University of Texas at Austin.
Thiabendazole—an FDA-approved, generic drug taken orally that has been in clinical use for 40 years as an antifungal—is not currently used for cancer therapy.
Full story at Futurity.
Photo credit: Hye Ji Cha
0 Comments